Connect with us

Business

Is the CSL (ASX:CSL) vaccine business under threat?

Published

on

Image source: Getty Images

The CSL Limited (ASX: CSL) share price has been underperforming the ASX 200 in 2021.

Since the start of the year, the biotherapeutics company’s shares are down 2%. This compares to a 10% gain by the benchmark index.

Why is the CSL share price…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending